GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023
20 Octubre 2023 - 6:00AM
Business Wire
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will
host a conference call and webcast to report third quarter 2023
financial results on Friday, November 3, 2023, at 8:30 a.m. ET.
To access the call by phone, please go to this registration link
and you will be provided with dial in details. Participants are
encouraged to connect 15 minutes in advance of the scheduled start
time.
A live webcast of the call will be available on the “Investors”
tab on the GlycoMimetics website. A webcast replay will be
available for 30 days following the call.
About GlycoMimetics, Inc.
GlycoMimetics is a late clinical-stage biotechnology company
discovering and developing glycobiology-based therapies for
cancers, including AML, and for inflammatory diseases. The
company’s science is based on an understanding of the role that
carbohydrates play in cell recognition. Its specialized chemistry
platform is being deployed to discover small molecule drugs--known
as glycomimetics--that alter carbohydrate-mediated recognition in
diverse disease states, including cancers and inflammation. As a
leader in this science, GlycoMimetics leverages this unique
approach to advance its pipeline of wholly-owned drug candidates
with the goal of developing transformative therapies for diseases
with high unmet medical need. GlycoMimetics is headquartered in
Rockville, MD in the BioHealth Capital Region. Learn more at
www.glycomimetics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231020147716/en/
Investors: Argot Partners Leo Vartorella 212-600-1902
Glycomimetics@argotpartners.com
Public Relations: Geoff Cook 973-652-7929
GlycoMimetics (NASDAQ:GLYC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
GlycoMimetics (NASDAQ:GLYC)
Gráfica de Acción Histórica
De May 2023 a May 2024